Skip to main content

Medical-Surgical Nursing (10 cr)

Code: AH00BZ49-3018

General information


Enrollment

01.07.2021 - 05.09.2021

Timing

22.10.2021 - 27.02.2022

Number of ECTS credits allocated

10 op

Virtual portion

5 op

RDI portion

2 op

Mode of delivery

50 % Contact teaching, 50 % Distance learning

Unit

Faculty of Health Care and Social Services (LAB)

Campus

Lahti Campus

Teaching languages

  • Finnish

Seats

0 - 40

Degree programmes

  • Bachelor's Degree Programme in Nursing

Teachers

  • Fanny Kilpinen
  • Hanna Laine
  • Anni Koponen

Scheduling groups

  • Verkkoluento 1 (Size: 0. Open UAS: 0.)
  • Verkkoluento 2 (Size: 0. Open UAS: 0.)
  • Verkkoluento 1 (Size: 0. Open UAS: 0.)
  • Verkkoluento 2 (Size: 0. Open UAS: 0.)
  • Verkkoluento 3 (Size: 0. Open UAS: 0.)
  • Verkkoluento 4 (Size: 0. Open UAS: 0.)
  • Harjoitus R 3 (Size: 0. Open UAS: 0.)
  • Harjoitus R 4 (Size: 0. Open UAS: 0.)
  • Harjoitus R 1 (Size: 0. Open UAS: 0.)
  • Harjoitus R 2 (Size: 0. Open UAS: 0.)
  • Harjoitus R 3 (Size: 0. Open UAS: 0.)
  • Harjoitus R 4 (Size: 0. Open UAS: 0.)
  • Harjoitus R 1 (Size: 0. Open UAS: 0.)
  • Harjoitus R 2 (Size: 0. Open UAS: 0.)
  • Harjoitus R1 ja R2 (Size: 0. Open UAS: 0.)
  • Harjoitus R3 ja R4 (Size: 0. Open UAS: 0.)
  • Luennot 1 (Size: 0. Open UAS: 0.)

Groups

  • HLTISH21S

Small groups

  • Verkkoluento 1
  • Verkkoluento 2
  • Verkkoluento 1
  • Verkkoluento 2
  • Verkkoluento 3
  • Verkkoluento 4
  • Harjoitus R 3
  • Harjoitus R 4
  • Harjoitus R 1
  • Harjoitus R 2
  • Harjoitus R 3
  • Harjoitus R 4
  • Harjoitus R 1
  • Harjoitus R 2
  • Harjoitus R 1
  • Harjoitus R 1
  • Luennot 1

Learning outcomes

The student is able to
- define primary treatment paths and processes of a medical-surgical and perioperative client
- assess the treatment needs of a medical-surgical client and implement key nursing measures
- apply knowledge of the primary medical-surgical diseases in nursing care
- apply knowledge of pathophysiology and pharmacology in medical-surgical nursing care and safe pharmacology

Assessment scale

1-5